Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Inflammatory Myopathies in Children

Angela Byun Robinson, MD, and Ann M. Reed, MD  |  Issue: July 2012  |  July 10, 2012

The Case

A previously healthy four-year-old female presents with a history of not being able to walk for more than a few minutes and complaining of leg pain when playing. Her parents confirm she has not been willing to play on the floor recently and wants to be carried while out walking. She developed a red rash on her cheeks and knees with occasional fever and irritability. She was seen by her primary care provider and was referred to a pediatric rheumatologist for possible juvenile arthritis. On further questioning, it is discovered that she has been losing weight and has been more irritable.

Her evaluation demonstrated decreased ability to straighten her elbow, fingers, and knees. She has erythema of her metacarpophalangeal joints (MCPs), proximal interphalangeal joints, and knees, as well as on her forehead, cheeks, and chin, with sparing of her nasolabial folds. Telangiectasias are seen on the gum line and in the periungual fingernail region. During your evaluation, she cried when you tried to test muscle strength and she was unwilling or unable to sit on the floor.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

You obtain blood tests, which include a normal complete blood count and erythrocyte sedimentation rate, while her aldolase, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase are elevated with a normal creatine kinase. The antinuclear antibody (ANA) is positive and anti-Sm, -RNP, -SSA, and -SSB antibodies are all negative. An MRI of the thigh/knee demonstrates diffuse muscle edema and a normal knee joint.

A muscle biopsy demonstrates diffuse perivascular and perfascicular inflammation, MHC class I upregulation, MAC deposition, and microvascular thrombosis consistent with juvenile dermatomyositis (JDM).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Thus, this child has classic findings of JDM—what would be initial therapy options?

JDM is the most common subset of the juvenile idiopathic inflammatory myopathies (IIM), representing about 85% of the IIM cases in patients aged 16 years or younger.1 The incidence of JDM in the United States is 3.2 per million children per year.2 It is more common in females, with an average age of onset of seven years of age. One-fourth of the patients are less than four years of age at onset.3

Clinical Features of JDM

JDM usually presents as easy fatigability, irritability in a young child, and inability or refusal to perform normal daily activity such as getting up off the floor, climbing stairs, playing, dressing, etc. The onset of muscle weakness is usually insidious and, at times, blamed on behavior issues. There is usually difficulty with and gradually increasing fatigue in activities of daily living, such as combing hair, reaching for highly placed objects, climbing stairs, or getting in or out of bed. The onset of rash, muscle weakness, and fatigability may be months apart or in the same time frame.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ANA titerdrugHYDROXYCHLOROQUINEinflammationinflammatory myopathyintravenous immune globulinjuvenile dermatomyositisMethotrexatepatient carePediatricsrheumatologistrituximab

Related Articles
    Oksana Kuzmina/shutterstock.comx

    Environmental Factors in Pediatric Systemic Autoimmune Diseases

    March 20, 2017

    Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…

    Updates in Juvenile Dermatomyositis: Pathogenesis & Patient Care

    July 17, 2021

    Experts provided an update on juvenile dermatomyositis, discussing patient care, treatment options and the pathogenesis of disease.

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Reading RHEUM

    November 1, 2006

    Handpicked Reviews of Contemporary Literature

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences